Cytarabine (liposomal) 50mg/5ml suspension for injection vials
| ID | 7591711000001106 |
|---|---|
| Therapeutic Moiety | Cytarabine (liposomal) |
| Name | Cytarabine (liposomal) 50mg/5ml suspension for injection vials |
| Abbreviated name | Cytarabine (liposomal) 50mg/5ml inj vials |
| Preferred name basis | rINN - Recommended International Non-proprietary |
| Date of name applicability | 21 Jun 2007 |
| Previous name | Cytarabine 50mg/5ml suspension for injection vials |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Non-availability indicator | Actual Products not Available |
| Non availability status date | 5 Nov 2019 |
| Dose form | Discrete |
| Unit dose form size | 5.000 |
| Unit dose form units | ml |
| Unit dose unit of measure | vial |
| Ingredients | Cytarabine liposomal pegylated |
| Form & Route | suspensioninjection.intrathecal |
| Drug formulations | Suspension for injection |
| Drug route | Intrathecal |
| Control drug | No Controlled Drug Status |